end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableAndAccruedLiabilitiesCurrent,AccountsPayableAndOtherAccruedLiabilities,AccountsPayableAndOtherAccruedLiabilities,AccountsPayableTradeCurrentAndNoncurrent,AccountsReceivableNetCurrent,AccruedLiabilitiesAndOtherLiabilities,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AccumulatedDepreciationDepletionAndAmortizationReclassificationsFromPropertyPlantAndEquipment1,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalWarrantIssued,AllocatedShareBasedCompensationExpense,AmortizationOfIntangibleAssets,Assets,AssetsCurrent,AssetsHeldInTrust,Cash,CashAndCashEquivalentsAtCarryingValue,CashAndCashEquivalentsFairValueDisclosure,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,DeferredCostsCurrentAndNoncurrent,DeferredOfferingCosts,DeferredTaxAssetsCapitalLossCarryforwards,DeferredTaxAssetsGoodwillAndIntangibleAssets,DeferredTaxAssetsLiabilitiesNet,DeferredTaxAssetsPropertyPlantAndEquipment,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits,Depreciation,DepreciationAndAmortization,DepreciationDepletionAndAmortization,DepreciationExpenseOnReclassifiedAssets,DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet,DerivativeLiabilities,DerivativeLiabilitiesNoncurrent,EarningsPerShareBasicAndDiluted,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,EmployeeBenefitsAndShareBasedCompensation,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,FairValueAdjustmentOfWarrants,FiniteLivedIntangibleAssetsAccumulatedAmortization,FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths,FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive,FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive,FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour,FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree,FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo,FiniteLivedIntangibleAssetsGross,FiniteLivedIntangibleAssetsNet,ForeignCurrencyTransactionGainLossBeforeTax,ForeignCurrencyTransactionGainLossRealized,ForeignCurrencyTransactionGainLossRealized,ForeignCurrencyTransactionGainLossRealized,ForeignCurrencyTransactionGainLossUnrealized,GainLossOnDispositionOfAssets,GainLossOnSaleOfOtherAssets,GeneralAndAdministrativeExpense,IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance,IncomeTaxReconciliationChangeInEnactedTaxRate,IncomeTaxReconciliationForeignIncomeTaxRateDifferential,IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate,IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost,IncomeTaxReconciliationTaxCreditsOther,IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,IncreaseDecreaseInAccountsReceivable,IncreaseDecreaseInOtherNoncurrentAssets,IncreaseDecreaseInPrepaidExpensesOther,IntangibleAssetsNetExcludingGoodwill,InvestmentIncomeInterest,InvestmentInterestRate,LeaseholdImprovementsGross,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearFive,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NotesReceivableRelatedPartiesCurrent,NumberOfOperatingSegments,OperatingExpenses,OperatingLeaseExpense,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeaseRightOfUseAsset,OperatingLossCarryforwards,OtherAssetsNoncurrent,OtherMinorityInterests,OtherNonoperatingIncomeExpense,OtherShortTermInvestments,PaymentsOfDebtIssuanceCosts,PaymentsOfFinancingCosts,PaymentsOfStockIssuanceCosts,PaymentsToAcquirePropertyPlantAndEquipment,PaymentsToAcquireShortTermInvestments,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfPrivatePlacement,ProceedsFromIssuanceOfWarrants,ProceedsFromSaleOfPropertyPlantAndEquipment,ProceedsFromSaleOfShortTermInvestments,ProfitLoss,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,PropertyPlantAndEquipmentSalvageValuePercentage,RepaymentsOfLongTermCapitalLeaseObligations,ResearchAndDevelopmentExpense,RetainedEarningsAccumulatedDeficit,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue,ShortTermInvestments,StockholdersEquity,StockIssued1,StockIssuedDuringPeriodSharesOther,StockIssuedDuringPeriodValueOther,UnrealizedGainLossOnDerivatives,VariableLeaseCost,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,AccruedRoyaltiesCurrentAndNoncurrent,BusinessAcquisitionsProFormaNetIncomeLoss,BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles,CostOfRevenue,DeferredRevenueCurrent,DeferredTaxAssetsInProcessResearchAndDevelopment,FiniteLivedIntangibleAssetAcquiredInPlaceLeases,FiniteLivedPatentsGross,FiniteLivedTrademarksGross,Goodwill,GrossProfit,IncreaseDecreaseInDeferredRevenue,IncreaseDecreaseInInventories,InterestIncomeExpenseNet,InventoryFinishedGoods,InventoryNet,InventoryRawMaterialsNetOfReserves,LegalFees,LesseeOperatingLeaseDiscountRate,OperatingIncomeLoss,OperatingLeaseLeaseIncomeLeasePayments,OtherNonoperatingIncome,RepaymentsOfDebt,RestrictedCashNoncurrent,RevenueFromContractWithCustomerExcludingAssessedTax,Revenues,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod,ShortTermBorrowings,StockIssuedDuringPeriodValueNewIssues
2020-09-30,2020-12-17,10-Q,INMED PHARMACEUTICALS INC.,INM,CIK0001728328,CAD,1802628.0,333866.0,250293.0,152742.0,51873.0,497999.0,147164.0,6384.0,-172474.0,17849740.0,,85407.0,21597.0,6603674.0,5116527.0,,3851615.0,4497296.0,,4497296.0,-1308513.0,,5220707.0,5220707.0,53065240.0,-1469679.0,171717.0,128907.0,,,,,655144.0,21351.0,27981.0,27981.0,21351.0,,,,-0.31,,127725.0,85407.0,198725.0,148980.0,,568773.0,92078.0,,92078.0,92078.0,92078.0,92078.0,1657403.0,1088630.0,-39499.0,,,77992.0,129400.0,,,624788.0,,,,,,,160719.0,5554.0,14007.0,31681.0,1088630.0,4345.0,,6384.0,363322.0,89222.0,274100.0,2109628.0,6603674.0,1874030.0,-64648.0,,-1371590.0,-1599079.0,,,1563925.0,20728.0,385057.0,71402.0,235598.0,,,13988.0,915682.0,,43107.0,,64648.0,,,,524196.0,,,,,,1600000.0,531693.0,384529.0,,16244.0,911156.0,-66248460.0,85407.0,,,,31818.0,8.19,6.14,,556817.0,14.96,11.22,,,,,43162.0,4494046.0,,,,,,5220707.0,5220707.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2020-12-31,2021-02-11,10-Q,INMED PHARMACEUTICALS INC.,INM,CIK0001728328,CAD,2077325.0,7667898.0,6022540.0,930393.0,154846.0,364841.0,183198.0,6528.0,128569.0,17946374.0,,96634.0,30288.0,11747422.0,10249388.0,,3043954.0,10020853.0,10020853.0,10020853.0,,,7000707.0,7000707.0,58008112.0,-1942739.0,328845.0,328845.0,,,,,552660.0,,36816.0,,21828.0,242628.0,1763980.0,1763980.0,-0.37,,,,939133.0,737616.0,,626885.0,96468.0,,96468.0,96468.0,96468.0,96468.0,1736420.0,1109535.0,-194792.0,,,,301043.0,,,959554.0,,,,,,,,,,,1109535.0,3050.0,,,581519.0,156213.0,425306.0,4156609.0,11747422.0,2153637.0,,,,-2243782.0,,,1934318.0,,385057.0,76312.0,238992.0,,,14655.0,6976899.0,-360350.0,45162.0,,,,,,28464.0,,,,,,,557042.0,373844.0,,,937948.0,-68492242.0,96634.0,,,,,,,,896067.0,,,,,,,45225.0,7590813.0,,,6052000.0,242628.0,,6091359.0,6091359.0,,-2914379.0,,,,,,,,,,,,-360350.0,,,,,,-2243782.0,,,,10020853.0,276790.0,,,,,6052000.0
2021-03-31,2021-05-13,10-Q,INMED PHARMACEUTICALS INC.,INM,CIK0001728328,CAD,1635477.0,2438694.0,1939249.0,795343.0,70300.0,65569.0,209151.0,3633.0,128569.0,21292201.0,,207302.0,23788.0,12344999.0,10896704.0,,3460601.0,9454113.0,9454113.0,9454113.0,,,8050707.0,8050707.0,60587417.0,-3101475.0,,138927.0,,,,,582502.0,,27421.0,,22327.0,,1763980.0,,-0.41,,,,,527122.0,,650672.0,96467.0,,96467.0,96467.0,96467.0,96467.0,1736420.0,1085748.0,28467.0,,,,,,,1333725.0,,,,,,,,,,,1085748.0,3797.0,,,588759.0,158158.0,430601.0,1930529.0,12344999.0,1714295.0,,,,-3101475.0,,,3133739.0,,385057.0,78818.0,216234.0,,,14655.0,5993512.0,,,,,,,,1326526.0,,,,,,,557043.0,347892.0,,,1772593.0,-71593717.0,207302.0,,,,,,,,891521.0,,,,,,,45765.0,10414470.0,,,,,,7549040.0,7549040.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-06-30,2021-09-24,10-K,INMED PHARMACEUTICALS INC.,INM,CIK0001728328,CAD,2134878.0,1532950.0,1236784.0,775129.0,11919.0,169641.0,222600.0,,128569.0,21513051.0,,610193.0,99723.0,9781216.0,8378269.0,,7053329.0,7363126.0,7363126.0,7363126.0,1557317.0,,8050707.0,8050707.0,60587417.0,-9772646.0,112075.0,112074.0,13742381.0,-181845.0,259457.0,,880207.0,,120866.0,120866.0,,242628.0,,,-1.52,0.27,494960.0,610193.0,,371777.0,,674723.0,,96468.0,96468.0,96468.0,96468.0,96468.0,1736420.0,1061697.0,-163101.0,80713.0,27428.0,,430443.0,-555.0,,4479333.0,4109545.0,99490.0,-1074000.0,-2754834.0,-390685.0,10484.0,346685.0,-40198.0,14161.0,823172.0,1061697.0,16017.0,,,312442.0,98729.0,213713.0,2404649.0,9781216.0,2215361.0,10854722.0,-1725.0,-9790640.0,-10203089.0,,1.0,9938283.0,107828.0,385057.0,80483.0,189288.0,,50897706.0,14655.0,309796.0,-360350.0,46391.0,,1617778.0,,1725.0,,956762.0,12472500.0,11000000.0,,,,10200000.0,549195.0,326595.0,0.3,93951.0,5338084.0,-74852470.0,610193.0,0.0,0.0027,1.0588,37879.0,,,361250.0,912006.0,,,,,,1.96,46462.0,7376567.0,,,6052000.0,,63334.0,6719830.0,6719830.0,,,,,,,1736420.0,,,,,,,,,,,,,,,,,,,,,,,
2021-09-30,2021-11-10,10-Q,INMED PHARMACEUTICALS INC.,INM,CIK0001728328,CAD,1844769.0,2443919.0,1918232.0,1255946.0,14842.0,137552.0,244261.0,4217.0,128569.0,29230464.0,739920.0,111142.0,24315.0,17327264.0,15976323.0,,7109169.0,15343905.0,,15343905.0,7980779.0,,10327034.0,10327034.0,63686724.0,-2971615.0,179118.0,,,,,,273154.0,,28532.0,28532.0,21343.0,,,,-0.25,,,111142.0,,247519.0,,699038.0,,96468.0,96468.0,96468.0,96468.0,96468.0,1736420.0,1037382.0,-84112.0,,,83800.0,,,,1372867.0,,,,,,,-469227.0,2923.0,-6030.0,-634410.0,1037382.0,5148.0,0.15,,,,,2105592.0,17327264.0,1927001.0,10884696.0,-250000.0,-2653917.0,-2971615.0,250000.0,,2892651.0,25906.0,,82232.0,178591.0,,,8625.0,8234736.0,,45132.0,,1115129.0,,,,322352.0,11999825.0,,,,,3000000.0,549195.0,304934.0,,17411.0,1491252.0,-77824085.0,111142.0,,,,,,,,,,,,,,,45224.0,15221672.0,739920.0,,139.0,,61615.0,12047555.0,12047555.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-12-31,2022-02-14,10-Q,INMED PHARMACEUTICALS INC.,INM,CIK0001728328,CAD,3358489.0,2638499.0,2081248.0,1706680.0,50304.0,382114.0,320520.0,6246.0,128569.0,27049042.0,,214779.0,43551.0,19383720.0,12505026.0,,8313978.0,11279964.0,,11279964.0,,,14137034.0,14137034.0,69096601.0,-4282814.0,,,,,,,447696.0,,49797.0,,88265.0,,,,-0.31,,,,,618617.0,,742589.0,,184649.0,184649.0,184649.0,184649.0,184649.0,1736420.0,2400831.0,3007.0,,,,,,,1836786.0,,,,,,,,,,,2400831.0,4222.0,,,,,,5216407.0,19383720.0,4617765.0,,,,-4282814.0,,,4423653.0,,825427.0,391805.0,598642.0,728115.0,,109175.0,2965986.0,,45356.0,,,,,,140512.0,,,,,,,1417169.0,1096649.0,,,2537070.0,-82106899.0,214779.0,,,,,,,,,,,,,,,45424.0,14167313.0,,,,,,13847360.0,13847360.0,300000.0,-4224983.0,2656000.0,153537.0,8390.0,1249000.0,3143420.0,1191000.0,216000.0,2023039.0,111555.0,,,,162143.0,988822.0,826679.0,,0.04,-4282814.0,,22055.0,,11279964.0,265092.0,265092.0,1.4,,58624.0,
